Erythrophagocytosis by plasmacytoid dendritic cells and monocytes is enhanced during inflammation

Transfusion

Volumn 56, Issue 4, 2016, Pages 905-916

  Richards, Amanda L ^a   Hendrickson, Jeanne E ^b   Zimring, James C ^a,c   Hudson, Krystalyn E ^a  

^a Bloodworks NW Research Institute ^*  (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,3' DIHEXYLOXACARBOCYANINE; B7 ANTIGEN; CD86 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; POLYINOSINIC POLYCYTIDYLIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; ERYTHROCYTE; ERYTHROCYTE TRANSFUSION; ERYTHROPHAGOCYTOSIS; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GRANULOCYTE; HUMORAL IMMUNITY; INFLAMMATION; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; PLASMACYTOID DENDRITIC CELL; SPLEEN CELL; ANIMAL; C57BL MOUSE; CELL PHAGOCYTOSIS; DRUG EFFECTS; IMMUNOLOGY; PATHOLOGY; PHYSIOLOGY; SPLEEN; UPREGULATION;

ANIMALS; CYTOPHAGOCYTOSIS; DENDRITIC CELLS; ERYTHROCYTES; INFLAMMATION; MACROPHAGES; MICE; MICE, INBRED C57BL; MONOCYTES; POLY I-C; SPLEEN; UP-REGULATION;

EID: 84956899190     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13497     Document Type: Article

References (41)

1. Klein H, Anstee D., Mollison's blood transfusion in clinical medicine. 11th ed. Oxford: Blackwell Publishing; 2005.
2. Moise KJ., Fetal anemia due to non-Rhesus-D red-cell alloimmunization. Semin Fetal Neonatal Med 2008; 13: 207-14.
3. Urbaniak SJ, Greiss MA., RhD haemolytic disease of the fetus and the newborn. Blood Rev 2000; 14: 44-61.
4. Chou ST, Liem RI, Thompson AA., Challenges of alloimmunization in patients with haemoglobinopathies. Br J Haematol 2012; 159: 394-404.
5. Gehrs BC, Friedberg RC., Autoimmune hemolytic anemia. Am J Hematol 2002; 69: 258-71.
6. Blum JS, Wearsch PA, Cresswell P., Pathways of antigen processing. Annu Rev Immunol 2013; 31: 443-73.
7. Ganguly D, Haak S, Sisirak V, et al., The role of dendritic cells in autoimmunity. Nat Rev Immunol 2013; 13: 566-77.
8. Alberts B, Johnson A, Lewis J, et al., Molecular biology of the cell. 4th ed. New York: Garland Science; 2002.
9. Dominguez PM, Ardavin C., Differentiation and function of mouse monocyte-derived dendritic cells in steady state and inflammation. Immunol Rev 2010; 234: 90-104.
10. Murray PJ, Wynn TA., Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 2011; 11: 723-37.
11. Merad M, Sathe P, Helft J, et al., The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu Rev Immunol 2013; 31: 563-604.
12. Kawai T, Akira S., The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010; 11: 373-84.
13. Akira S, Uematsu S, Takeuchi O., Pathogen recognition and innate immunity. Cell 2006; 124: 783-801.
14. Fadok VA, Bratton DL, Henson PM., Phagocyte receptors for apoptotic cells: recognition, uptake, and consequences. J Clin Invest 2001; 108: 957-62.
15. Redman M, Regan F, Contreras M., A prospective study of the incidence of red cell Allo-immunisation following transfusion. Vox Sang 1996; 71: 216-20.
16. Schonewille H, Van De Watering LM, Loomans DS, et al., Red blood cell alloantibodies after transfusion: factors influencing incidence and specificity. Transfusion 2006; 46: 250-6.
17. Rosse WF, Gallagher D, Kinney TR, et al., Transfusion and alloimmunization in sickle cell disease. The cooperative study of sickle cell disease. Blood 1990; 76: 1431-7.
18. Yazdanbakhsh K, Ware RE, Noizat-Pirenne F., Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management. Blood 2012; 120: 528-37.
19. Hendrickson JE, Desmarets M, Deshpande SS, et al., Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells. Transfusion 2006; 46: 1526-36.
20. Hendrickson JE, Chadwick TE, Roback JD, et al., Inflammation enhances consumption and presentation of transfused RBC antigens by dendritic cells. Blood 2007; 110: 2736-43.
21. Yu J, Heck S, Yazdanbakhsh K., Prevention of red cell alloimmunization by CD25 regulatory T cells in mouse models. Am J Hematol 2007; 82: 691-6.
22. de Back DZ, Kostova EB, van Kraaij M, et al., Of macrophages and red blood cells; a complex love story. Front Physiol 2014; 5: 9.
23. Knutson M, Wessling-Resnick M., Iron metabolism in the reticuloendothelial system. Crit Rev Biochem Mol Biol 2003; 38: 61-88.
24. Idoyaga J, Suda N, Suda K, et al., Antibody to Langerin/CD207 localizes large numbers of CD8alpha+ dendritic cells to the marginal zone of mouse spleen. Proc Natl Acad Sci U S A 2009; 106: 1524-9.
25. Duriancik DM, Hoag KA., The identification and enumeration of dendritic cell populations from individual mouse spleen and Peyer's patches using flow cytometric analysis. Cytometry 2009; 75A: 951-9.
26. Hey YY, O'Neill HC., Murine spleen contains a diversity of myeloid and dendritic cells distinct in antigen presenting function. J Cell Mol Med 2012; 16: 2611-9.
27. Rose S, Misharin A, Perlman H., A novel Ly6C/Ly6G-based strategy to analyze the mouse splenic myeloid compartment. Cytometry 2012; 81A: 343-50.
28. Gordon S, Taylor PR., Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005; 5: 953-64.
29. Swirski F, Nahrendorf M, Etzrodt M, et al., Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 2009; 325: 612-6.
30. Hudson KE, Hendrickson JE, Cadwell CM, et al., Partial tolerance of autoreactive B and T cells to erythrocyte-specific self-antigens in mice. Haematologica 2012; 97: 1836-44.
31. Murakami M, Honjo T., Anti-red blood cell autoantibody transgenic mice: murine model of autoimmune hemolytic anemia. Semin Immunol 1996; 8: 3-9.
32. Miller E, Bhardwaj N., A bloody mess: dendritic cells use hemophagocytosis to regulate viral inflammation. Immunity 2013; 39: 429-31.
33. Ohyagi H, Onai N, Sato T, et al., Monocyte-derived dendritic cells perform hemophagocytosis to fine-tune excessive immune responses. Immunity 2013; 39: 584-98.
34. Hod EA, Arinsburg SA, Francis RO, et al., Use of mouse models to study the mechanisms and consequences of RBC clearance. Vox Sang 2010; 99: 99-111.
35. Clark MR, Massenburg D, Zhang M, et al., Molecular mechanisms of B cell antigen receptor trafficking. Ann N Y Acad Sci 2003; 987: 26-37.
36. Inaba K, Swiggard WJ, Steinman RM, et al., Isolation of dendritic cells. Curr Protoc Immunol 2001;Chapter 3:Unit 3.7.
37. Kim S, Kaiser V, Beier E, et al., Self-priming determines high type I IFN production by plasmacytoid dendritic cells. Eur J Immunol 2014; 44: 807-18.
38. Farina GA, York MR, Di Marzio M, et al., Poly(I:C) drives type I IFN- and TGFβ-mediated inflammation and dermal fibrosis simulating altered gene expression in systemic sclerosis. J Invest Dermatol 2010; 130: 2583-93.
39. Szeles L, Meissner F, Dunand-Sauthier I, et al., TLR3-mediated CD8+ dendritic cell activation is coupled with establishment of a cell-intrinsic antiviral state. J Immunol 2015; 195: 1025-33.
40. Fuchsberger M, Hochrein H, O'Keeffe M., Activation of plasmacytoid dendritic cells. Immunol Cell Biol 2005; 83: 571-7.
41. Asselin-Paturel C, Brizard G, Chemin K, et al., Type I interferon dependence of plasmacytoid dendritic cell activation and migration. J Exp Med 2005; 201: 1157-67.